British Journal of Cancer

Springer Nature

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

British Journal of Cancer is a journal published by Springer Nature in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,690 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Nature
ISSN
0007-0920 · 1532-1827
Country
United Kingdom
Access
Not open access / not declared
Declared publication charge
4,690 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1965-01-01
  • PUBMED · 2001-01-05
Indexing
MEDLINE · PUBMED
APC
4,690 EUR
Declared review time (DOAJ)
—
Actual review time (measured)
208 days received→accepted — computed from PubMed (n=94)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

28588

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

346

i10-index

21408

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2027
Level 2 — top tier (~20% of the field's channels)
Open references deposited at Crossref
94%
ORCID iDs in current deposits
96%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity4
Alternate titles
BJC
Source type
journal
NLM unique ID (PubMed)
0370635
Society affiliations
Cancer Research UK
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Global Cancer Incidence and Screening
  • Global Cancer Incidence and Screening
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis
Show all subjects (50)
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Treatments and Studies
  • Cancer-related Molecular Pathways
  • Cancer-related Molecular Pathways
  • Immunotherapy and Immune Responses
  • Estrogen and related hormone effects
  • Immunotherapy and Immune Responses
  • Estrogen and related hormone effects
  • Genetic factors in colorectal cancer
  • Genetic factors in colorectal cancer
  • Cancer Risks and Factors
  • Cancer Risks and Factors
  • HER2/EGFR in Cancer Research
  • HER2/EGFR in Cancer Research
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • Ovarian cancer diagnosis and treatment
  • Ovarian cancer diagnosis and treatment
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
  • Pancreatic and Hepatic Oncology Research
  • Pancreatic and Hepatic Oncology Research
  • Colorectal Cancer Screening and Detection
  • Colorectal Cancer Screening and Detection
  • Cancer therapeutics and mechanisms
  • Cancer therapeutics and mechanisms
  • Lung Cancer Research Studies
  • Lung Cancer Research Studies
  • Cancer Research and Treatments
  • Cancer Research and Treatments
  • Angiogenesis and VEGF in Cancer
  • Angiogenesis and VEGF in Cancer
  • Gastric Cancer Management and Outcomes
  • Gastric Cancer Management and Outcomes
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: